Halyard Health Stock Price, News & Analysis (NYSE:HYH)

$47.91 +0.60 (+1.27 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$47.91
Today's Range$47.05 - $47.99
52-Week Range$35.24 - $50.99
Volume160,020 shs
Average Volume282,462 shs
Market Capitalization$2.22 billion
P/E Ratio40.26
Dividend YieldN/A
Beta1.71

About Halyard Health (NYSE:HYH)

Halyard Health logoHalyard Health, Inc. is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections. The Company address healthcare needs, such as reducing the use of opioids, while helping patients move from surgery to recovery. The Medical Devices segment's products include post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems and enteral feeding tubes. The S&IP segment includes product offerings, such as sterilization wrap, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves.

Receive HYH News and Ratings via Email

Sign-up to receive the latest news and ratings for HYH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryN/A
SectorMedical
SymbolNYSE:HYH
CUSIPN/A
Phone678-425-9273

Debt

Debt-to-Equity Ratio0.49%
Current Ratio2.13%
Quick Ratio1.19%

Price-To-Earnings

Trailing P/E Ratio40.2605042016807
Forward P/E Ratio23.03
P/E Growth2.48

Sales & Book Value

Annual Sales$1.59 billion
Price / Sales1.41
Cash Flow$3.43 per share
Price / Cash13.98
Book Value$23.62 per share
Price / Book2.03

Profitability

Trailing EPS$1.19
Net Income$39.80 million
Net Margins3.52%
Return on Equity8.65%
Return on Assets4.69%

Miscellaneous

Employees12,000
Outstanding Shares46,840,000

Halyard Health (NYSE:HYH) Frequently Asked Questions

What is Halyard Health's stock symbol?

Halyard Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "HYH."

How were Halyard Health's earnings last quarter?

Halyard Health Inc (NYSE:HYH) released its quarterly earnings data on Wednesday, November, 1st. The medical instruments supplier reported $0.60 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.47 by $0.13. The medical instruments supplier earned $401.40 million during the quarter, compared to analyst estimates of $394.54 million. Halyard Health had a net margin of 3.52% and a return on equity of 8.65%. The firm's revenue for the quarter was up 1.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.48 earnings per share. View Halyard Health's Earnings History.

When will Halyard Health make its next earnings announcement?

Halyard Health is scheduled to release their next quarterly earnings announcement on Tuesday, February, 27th 2018. View Earnings Estimates for Halyard Health.

Where is Halyard Health's stock going? Where will Halyard Health's stock price be in 2018?

4 analysts have issued twelve-month target prices for Halyard Health's stock. Their forecasts range from $42.00 to $52.00. On average, they expect Halyard Health's stock price to reach $47.00 in the next twelve months. View Analyst Ratings for Halyard Health.

What are Wall Street analysts saying about Halyard Health stock?

Here are some recent quotes from research analysts about Halyard Health stock:

  • 1. According to Zacks Investment Research, "Halyard Health, Inc. is a medical technology company. It is focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company sells surgical and infection prevention products for the operating room. Halyard offers products such as sterilization wraps, face masks, surgical drapes and gowns, closed suction catheters, pain pumps and enteral feeding tubes. It offers a range of medical device solutions including post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems, and enteral feeding tubes. Halyard Health, Inc. is headquartered in Alpharetta, Georgia. " (2/1/2018)
  • 2. Stifel Nicolaus analysts commented, "HYH closed 2016 with its fourth consecutive quarter of sales and EPS upside relative to both Consensus and management guidance. After a more difficult than expected first-year (2015) post-spin, in 2016, the company's transformation took clearer shape and was highlighted by: accretive M&A, a positive mix shift to the more profitable Medical Device franchise (38% of sales; 64% of operating profit), successful re-negotiations of material GPO contracts, significant organic cost-savings and stepped-up investments, all with significantly improved cash flow generation ($100M+ guide vs. $160M actual). We continue to believe HYH has further price appreciation potential ahead as '2016-like' thematic drivers continue playing out over the next 12-24 months. Still, we acknowledge that HYH shares (+56% TTM vs. S&P500: +23%) trading at 20x 2018E EPS (vs. large cap ~18x) could "pause" here as the stock absorbs the recent out-performance and the next wave of potentially positive catalysts becomes more visible. Yet to be realized sales, margin, and EPS-enhancing catalysts could include: IT cost savings, better S&IP pricing, more normal nitrile pricing and most important, further accretive M&A opportunities. Company-specific 2017 headwinds could include: more intense commodity price inflation, stepped up On-Q competition, and still uncertain macro tax-related legislation. For us, the bottom line is that HYH remains a positive long-term transformation story that is still in 'early innings' with significant opportunity both organically and through acquisitions to leverage earnings. We rate HYH Buy and raise our TP to $45 (from $38)." (2/28/2017)

Who are some of Halyard Health's key competitors?

Who are Halyard Health's key executives?

Halyard Health's management team includes the folowing people:

  • Ronald W. Dollens, Chairman of the Board (Age 70)
  • Joseph F. Woody, Chief Executive Officer, Director (Age 51)
  • Steven E. Voskuil, Chief Financial Officer, Senior Vice President (Age 48)
  • Rhonda D. Gibby, Chief Human Resource Officer, Senior Vice President (Age 49)
  • John W. Wesley, Senior Vice President, General Counsel (Age 59)
  • Christopher G. Isenberg, Senior Vice President - Global Supply Chain and Procurement (Age 50)
  • Warren J. Machan, Senior Vice President - Business Strategy (Age 51)
  • Gary D. Blackford, Independent Director (Age 60)
  • John P. Byrnes, Independent Director (Age 58)
  • William A. Hawkins III, Independent Director (Age 62)

Who owns Halyard Health stock?

Halyard Health's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (10.55%), Goldman Sachs Group Inc. (3.65%), Paradice Investment Management LLC (3.24%), Bank of New York Mellon Corp (1.96%), Macquarie Group Ltd. (1.83%) and Copper Rock Capital Partners LLC (1.45%). View Institutional Ownership Trends for Halyard Health.

Who sold Halyard Health stock? Who is selling Halyard Health stock?

Halyard Health's stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Schwab Charles Investment Management Inc., Gotham Asset Management LLC, Northpointe Capital LLC, Paradice Investment Management LLC, Metropolitan Life Insurance Co. NY, TIAA CREF Investment Management LLC and Guggenheim Capital LLC. View Insider Buying and Selling for Halyard Health.

Who bought Halyard Health stock? Who is buying Halyard Health stock?

Halyard Health's stock was purchased by a variety of institutional investors in the last quarter, including Channing Capital Management LLC, Macquarie Group Ltd., Deutsche Bank AG, Millennium Management LLC, Allianz Asset Management GmbH, Goldman Sachs Group Inc., MetLife Investment Advisors LLC and State of Wisconsin Investment Board. View Insider Buying and Selling for Halyard Health.

How do I buy Halyard Health stock?

Shares of Halyard Health can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Halyard Health's stock price today?

One share of Halyard Health stock can currently be purchased for approximately $47.91.

How big of a company is Halyard Health?

Halyard Health has a market capitalization of $2.22 billion and generates $1.59 billion in revenue each year. The medical instruments supplier earns $39.80 million in net income (profit) each year or $1.19 on an earnings per share basis. Halyard Health employs 12,000 workers across the globe.

How can I contact Halyard Health?

Halyard Health's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The medical instruments supplier can be reached via phone at 678-425-9273 or via email at [email protected]


MarketBeat Community Rating for Halyard Health (HYH)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  166 (Vote Outperform)
Underperform Votes:  173 (Vote Underperform)
Total Votes:  339
MarketBeat's community ratings are surveys of what our community members think about Halyard Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Halyard Health (NYSE:HYH) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.752.752.602.75
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $47.00$47.00$44.00$41.67
Price Target Upside: 0.70% downside0.70% downside7.04% downside0.03% downside

Halyard Health (NYSE:HYH) Consensus Price Target History

Price Target History for Halyard Health (NYSE:HYH)

Halyard Health (NYSE:HYH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/3/2017Stifel NicolausReiterated RatingBuy$52.00N/AView Rating Details
10/17/2017KeyCorpReiterated RatingHoldN/AView Rating Details
8/3/2017Deutsche BankBoost Price TargetBuy$35.00 -> $42.00MediumView Rating Details
8/3/2017StephensUpgradeEqual Weight -> OverweightMediumView Rating Details
1/6/2017JMP SecuritiesDowngradeOutperform -> Market Perform$38.00N/AView Rating Details
(Data available from 2/24/2016 forward)

Earnings

Halyard Health (NYSE:HYH) Earnings History and Estimates Chart

Earnings by Quarter for Halyard Health (NYSE:HYH)

Halyard Health (NYSE HYH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/26/2018$0.50N/AView Earnings Details
11/1/2017Q3 2017$0.47$0.60$394.54 million$401.40 millionViewN/AView Earnings Details
8/2/2017Q2 2017$0.37$0.51$399.16 million$399.20 millionViewListenView Earnings Details
5/2/2017Q1 2017$0.43$0.48$391.56 million$395.60 millionViewListenView Earnings Details
2/27/2017Q416$0.44$0.50$401.72 million$410.00 millionViewListenView Earnings Details
11/2/2016Q316$0.39$0.48$387.64 million$398.00 millionViewN/AView Earnings Details
8/3/2016Q216$0.36$0.45$383.08 million$400.00 millionViewN/AView Earnings Details
5/4/2016Q116$0.34$0.53$369.80 million$385.00 millionViewN/AView Earnings Details
2/29/2016Q415$0.50$0.57$401.96 million$401.40 millionViewListenView Earnings Details
11/3/2015Q315$0.47$0.52$388.00 million$390.00 millionViewN/AView Earnings Details
8/4/2015Q215$0.53$0.52$401.70 million$389.30 millionViewN/AView Earnings Details
5/4/2015Q1 2015$0.64$0.51$390.00 million$394.00 millionViewN/AView Earnings Details
3/4/2015Q4$0.75$1.59$425.10 million$439.40 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Halyard Health (NYSE:HYH) Earnings Estimates

Current Year EPS Consensus Estimate: $2.08 EPS
Next Year EPS Consensus Estimate: $2.14 EPS

Dividends

Dividend History for Halyard Health (NYSE:HYH)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Halyard Health (NYSE HYH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.30%
Institutional Ownership Percentage: 90.05%
Insider Trades by Quarter for Halyard Health (NYSE:HYH)
Insider Trades by Quarter for Halyard Health (NYSE:HYH)

Halyard Health (NYSE HYH) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/4/2015Robert E AbernathyCEOBuy10,000$31.06$310,600.0080,043View SEC Filing  
9/1/2015Steven E VoskuilCFOBuy1,000$30.00$30,000.0028,729View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Halyard Health (NYSE HYH) News Headlines

Source:
DateHeadline
Aperio Group LLC Has $1.57 Million Holdings in Halyard Health Inc (HYH)Aperio Group LLC Has $1.57 Million Holdings in Halyard Health Inc (HYH)
www.americanbankingnews.com - February 24 at 5:00 AM
Halyard Health (HYH) Scheduled to Post Quarterly Earnings on MondayHalyard Health (HYH) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - February 19 at 4:30 AM
 Analysts Anticipate Halyard Health Inc (HYH) to Post $0.49 Earnings Per Share Analysts Anticipate Halyard Health Inc (HYH) to Post $0.49 Earnings Per Share
www.americanbankingnews.com - February 18 at 1:34 PM
Halyard Health, Inc. To Webcast Conference Call Discussing Fourth Quarter and Full-Year 2017 Financial ResultsHalyard Health, Inc. To Webcast Conference Call Discussing Fourth Quarter and Full-Year 2017 Financial Results
finance.yahoo.com - February 13 at 9:52 AM
Halyard Health Inc (HYH) Given Average Rating of "Buy" by BrokeragesHalyard Health Inc (HYH) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - February 3 at 9:36 PM
Halyard Health Inc (HYH) Expected to Announce Quarterly Sales of $417.93 MillionHalyard Health Inc (HYH) Expected to Announce Quarterly Sales of $417.93 Million
www.americanbankingnews.com - February 3 at 4:38 AM
Halyard Health (HYH) Downgraded by Zacks Investment Research to HoldHalyard Health (HYH) Downgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - February 2 at 12:36 AM
 Brokerages Expect Halyard Health Inc (HYH) Will Announce Earnings of $0.49 Per Share Brokerages Expect Halyard Health Inc (HYH) Will Announce Earnings of $0.49 Per Share
www.americanbankingnews.com - January 15 at 3:08 PM
Head-To-Head Analysis: Meridian Bioscience (VIVO) & Halyard Health (HYH)Head-To-Head Analysis: Meridian Bioscience (VIVO) & Halyard Health (HYH)
www.americanbankingnews.com - January 13 at 11:26 AM
Halyard Health Inc (HYH) Given Consensus Rating of "Buy" by BrokeragesHalyard Health Inc (HYH) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - January 9 at 11:44 PM
Wired News – Owens & Minor Plans to Reorganize Business into Two Segments Post Acquisition of Halyard Healths S&IP BusinessWired News – Owens & Minor Plans to Reorganize Business into Two Segments Post Acquisition of Halyard Health's S&IP Business
finance.yahoo.com - January 8 at 8:26 AM
Halyard Health (HYH) Upgraded to Buy at Zacks Investment ResearchHalyard Health (HYH) Upgraded to Buy at Zacks Investment Research
www.americanbankingnews.com - January 7 at 6:40 PM
Halyard Health, Inc. to Present at the 36th Annual J.P. Morgan Healthcare ConferenceHalyard Health, Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 3 at 10:54 AM
Halyard Health (HYH) Upgraded to "Buy" at ValuEngineHalyard Health (HYH) Upgraded to "Buy" at ValuEngine
www.americanbankingnews.com - January 1 at 10:28 PM
Halyard Health, Inc. breached its 50 day moving average in a Bearish Manner : HYH-US : January 1, 2018Halyard Health, Inc. breached its 50 day moving average in a Bearish Manner : HYH-US : January 1, 2018
finance.yahoo.com - January 1 at 11:07 AM
Zacks: Analysts Anticipate Halyard Health Inc (HYH) Will Announce Quarterly Sales of $417.93 MillionZacks: Analysts Anticipate Halyard Health Inc (HYH) Will Announce Quarterly Sales of $417.93 Million
www.americanbankingnews.com - December 31 at 3:58 AM
Halyard Health, Inc. (HYH)Halyard Health, Inc. (HYH)
finance.yahoo.com - December 30 at 3:36 PM
$0.50 Earnings Per Share Expected for Halyard Health Inc (HYH) This Quarter$0.50 Earnings Per Share Expected for Halyard Health Inc (HYH) This Quarter
www.americanbankingnews.com - December 29 at 7:24 PM
ETFs with exposure to Halyard Health, Inc. : December 21, 2017ETFs with exposure to Halyard Health, Inc. : December 21, 2017
finance.yahoo.com - December 21 at 3:39 PM
Halyard Health Earns Relative Strength Rating Upgrade; Hits Key ThresholdHalyard Health Earns Relative Strength Rating Upgrade; Hits Key Threshold
finance.yahoo.com - December 20 at 11:30 AM
Halyard Health Inc (HYH) Receives Average Recommendation of "Buy" from AnalystsHalyard Health Inc (HYH) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - December 15 at 7:43 PM
Halyard Health, Inc. (HYH) Expected to Announce Earnings of $0.50 Per ShareHalyard Health, Inc. (HYH) Expected to Announce Earnings of $0.50 Per Share
www.americanbankingnews.com - December 12 at 3:28 PM
Halyard Health (HYH) Rating Increased to Buy at Zacks Investment ResearchHalyard Health (HYH) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - December 10 at 12:08 AM
Comparing Halyard Health (HYH) & Its CompetitorsComparing Halyard Health (HYH) & Its Competitors
www.americanbankingnews.com - December 8 at 9:08 PM
Halyard Health (HYH) Raised to "B" at TheStreetHalyard Health (HYH) Raised to "B" at TheStreet
www.americanbankingnews.com - December 6 at 10:38 PM
Financial Review: Halyard Health (HYH) versus Its CompetitorsFinancial Review: Halyard Health (HYH) versus Its Competitors
www.americanbankingnews.com - December 3 at 1:24 AM
Comparing Halyard Health (HYH) & The CompetitionComparing Halyard Health (HYH) & The Competition
www.americanbankingnews.com - December 2 at 9:38 AM
ETFs with exposure to Halyard Health, Inc. : December 1, 2017ETFs with exposure to Halyard Health, Inc. : December 1, 2017
finance.yahoo.com - December 1 at 4:46 PM
$418.06 Million in Sales Expected for Halyard Health, Inc. (HYH) This Quarter$418.06 Million in Sales Expected for Halyard Health, Inc. (HYH) This Quarter
www.americanbankingnews.com - November 26 at 2:52 AM
Reviewing Halyard Health (HYH) & The CompetitionReviewing Halyard Health (HYH) & The Competition
www.americanbankingnews.com - November 24 at 11:30 AM
Halyard Health, Inc. (HYH) Receives Consensus Rating of "Buy" from AnalystsHalyard Health, Inc. (HYH) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - November 20 at 7:52 PM
Halyard Health, Inc. breached its 50 day moving average in a Bearish Manner : HYH-US : November 15, 2017Halyard Health, Inc. breached its 50 day moving average in a Bearish Manner : HYH-US : November 15, 2017
finance.yahoo.com - November 17 at 6:13 PM
Analyzing Halyard Health (HYH) and Orthofix International N.V. (OFIX)Analyzing Halyard Health (HYH) and Orthofix International N.V. (OFIX)
www.americanbankingnews.com - November 16 at 11:14 PM
Halyard Health (HYH) & Its Peers Critical AnalysisHalyard Health (HYH) & Its Peers Critical Analysis
www.americanbankingnews.com - November 16 at 5:06 PM
Halyard Healths (HYH) Management Presents at Stifel Nicolaus Health Care Conference - Seeking AlphaHalyard Health's (HYH) Management Presents at Stifel Nicolaus Health Care Conference - Seeking Alpha
seekingalpha.com - November 15 at 1:10 AM
ETFs with exposure to Halyard Health, Inc. : November 13, 2017ETFs with exposure to Halyard Health, Inc. : November 13, 2017
finance.yahoo.com - November 13 at 7:41 PM
Sand In My Shoes - Pepsi Is Pouring DividendsSand In My Shoes - Pepsi Is Pouring Dividends
seekingalpha.com - November 11 at 10:26 AM
Halyard Health, Inc. to Present at Stifel 2017 Healthcare ConferenceHalyard Health, Inc. to Present at Stifel 2017 Healthcare Conference
finance.yahoo.com - November 8 at 9:28 PM
Halyard Health, Inc. :HYH-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017Halyard Health, Inc. :HYH-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017
finance.yahoo.com - November 8 at 9:28 PM
Halyard Health, Inc. (HYH) Expected to Announce Quarterly Sales of $415.46 MillionHalyard Health, Inc. (HYH) Expected to Announce Quarterly Sales of $415.46 Million
www.americanbankingnews.com - November 7 at 2:30 AM
Equities Analysts Set Expectations for Halyard Health, Inc.s FY2017 Earnings (HYH)Equities Analysts Set Expectations for Halyard Health, Inc.'s FY2017 Earnings (HYH)
www.americanbankingnews.com - November 6 at 4:56 AM
Halyard Health Meets 80-Plus Relative Strength Rating BenchmarkHalyard Health Meets 80-Plus Relative Strength Rating Benchmark
finance.yahoo.com - November 5 at 7:11 PM
Investors Buy High Volume of Halyard Health Call Options (HYH)Investors Buy High Volume of Halyard Health Call Options (HYH)
www.americanbankingnews.com - November 5 at 3:48 AM
Halyard Health, Inc. (HYH) Upgraded to Buy at ValuEngineHalyard Health, Inc. (HYH) Upgraded to Buy at ValuEngine
www.americanbankingnews.com - November 4 at 3:30 PM
ETFs with exposure to Halyard Health, Inc. : November 3, 2017ETFs with exposure to Halyard Health, Inc. : November 3, 2017
finance.yahoo.com - November 4 at 1:36 AM
Halyard Health, Inc. – Value Analysis (NYSE:HYH) : November 3, 2017Halyard Health, Inc. – Value Analysis (NYSE:HYH) : November 3, 2017
finance.yahoo.com - November 4 at 1:36 AM
Halyard Healths (HYH) Buy Rating Reaffirmed at Stifel NicolausHalyard Health's (HYH) Buy Rating Reaffirmed at Stifel Nicolaus
www.americanbankingnews.com - November 3 at 6:32 PM
Halyard Health, Inc. breached its 50 day moving average in a Bullish Manner : HYH-US : November 2, 2017Halyard Health, Inc. breached its 50 day moving average in a Bullish Manner : HYH-US : November 2, 2017
finance.yahoo.com - November 3 at 7:59 AM
Owens & Minor, Inc. -- Moodys places Owens & Minors ratings under review for downgradeOwens & Minor, Inc. -- Moody's places Owens & Minor's ratings under review for downgrade
finance.yahoo.com - November 3 at 7:59 AM
Corporate News Blog - Owens & Minor to Acquire Halyard’s S&IP BusinessCorporate News Blog - Owens & Minor to Acquire Halyard’s S&IP Business
finance.yahoo.com - November 3 at 7:59 AM

SEC Filings

Halyard Health (NYSE:HYH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Halyard Health (NYSE:HYH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Halyard Health (NYSE HYH) Stock Chart for Saturday, February, 24, 2018

Loading chart…

This page was last updated on 2/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.